Long-term survivors with metastatic uveal melanoma

Open Ophthalmology Journal

Volumn 6, Issue , 2012, Pages 49-53

  Buzzacco, Dominic M ^a   Abdel Rahman, Mohamed H ^a   Park, Stanley ^a   Davidorf, Frederick ^a   Olencki, Thomas ^a   Cebulla, Colleen M ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Alanine transaminase; Metastasis; Transpupillary thermal therapy and chemotherapy; Tumor; Uveal melanoma

Indexed keywords

IMATINIB; PROTEIN TYROSINE KINASE INHIBITOR; SORAFENIB; SUNITINIB; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASE;

ADULT; BRACHYTHERAPY; CANCER DIAGNOSIS; CANCER SURVIVAL; CANCER SURVIVOR; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; ENUCLEATION; FEMALE; HUMAN; LIVER METASTASIS; LIVER PERFUSION; LONG TERM CARE; MALE; METASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; PROTON RADIATION; RETROSPECTIVE STUDY; REVIEW; UVEA MELANOMA; AGED; ARTICLE; EXTERNAL BEAM RADIOTHERAPY; MIDDLE AGED; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 84863794769     PISSN: None     EISSN: 18743641     Source Type: Journal    
DOI: 10.2174/1874364101206010049     Document Type: Review

References (22)

1. Scotto J, Fraumeni JF Jr, Lee JA. Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J Natl Cancer Inst 1976; 56: 489-91.
2. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings. COMS report no. 10. Am J Ophthalmol 1998; 125: 779-96.
3. Diener-West M, Earle JD, Fine SL, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch Ophthalmol 2001; 119: 969-82.
4. Hawkins BS. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24. Am J Ophthalmol 2004; 138: 936-51.
5. Diener-West M, Reynolds SM, Agugliaro DJ, et al. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26. Arch Ophthalmol 2005; 123: 1639-43.
6. Collaborative Ocular Melanoma Study Group. Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15. Arch Ophthalmol 2001; 119: 670-6.
7. Gragoudas ES, Egan KM, Seddon JM, et al. Survival of patients with metastases from uveal melanoma. Ophthalmology 1991; 98: 383-9; discussion 390.
8. Rietschel P, Panageas KS, Hanlon C, Patel A, Abramson DH. Chapman PB. Variates of survival in metastatic uveal melanoma. J Clin Oncol 2005; 23: 8076-80.
9. Seddon JM, Albert DM, Lavin PT, Robinson N. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol 1983; 101: 1894-9.
10. Weinhaus RS, Seddon JM, Albert DM, Gragoudas ES, Robinson N. Prognostic factor study of survival after enucleation for juxtapapillary melanomas. Arch Ophthalmol 1985; 103: 1673-7.
11. Coupland SE, Campbell I, Damato B. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability. Ophthalmology 2008; 115: 1778-85.
12. Isager P, Ehlers N, Overgaard J. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas. Acta Ophthalmol Scand 2004; 82: 517-25.
13. Singh AD, Shields CL, Shields JA. Prognostic factors in uveal melanoma. Melanoma Res 2001; 11(3): 255-63.
14. Damato B, Duke C, Coupland SE, et al. Cytogenetics of uveal melanoma: a 7-year clinical experience. Ophthalmology 2007; 114: 1925-31.
15. Onken MD, Worley LA, Ehlers JP, Harbour JW. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 2004; 64: 7205-9.
16. Verma V, Abdel-Rahman M, Christopher B, Cebulla C, Davidorf F. Monosomy 3 status of metastatic uveal melanomas is associated with rapidly aggressive, therapy-resistant tumors. Invest Ophthalmol Vis Sci 2011; 52: ARVO E-Abstract 5383.
17. Rajpal S, Moore R, Karakousis CP. Survival in metastatic ocular melanoma. Cancer 1983; 52: 334-6.
18. Frenkel S, Nir I, Hendler K, et al. Long-term survival of uveal melanoma patients after surgery for liver metastases. Br J Ophthalmol 2009; 93: 1042-6.
19. Aoyama T, Mastrangelo MJ, Berd D, et al. Protracted survival after resection of metastatic uveal melanoma. Cancer 2000; 89: 1561-8.
20. Augsburger JJ, Correa ZM, Trichopoulos N. Surveillance testing for metastasis from primary uveal melanoma and effect on patient survival. Am J Ophthalmol 2011; 152: 5-9.e1.
21. Augsburger JJ, Correa ZM, Shaikh AH. Quality of evidence about effectiveness of treatments for metastatic uveal melanoma. Trans Am Ophthalmol Soc 2008; 106: 128-35; discussion 135-127.
22. Tijani LA, Luadadio M, Mastrangelo MJ, Sato T. Final results of a pilot study using sunitinib malate in patients with stage IV uveal melanoma. ASCO Annual Meeting; 2010 June 4-8; Chicago, Illinois. Abstracts 8577, 2010; p. 28.